WUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INC

WUXI BIOLOGICS (CAYMAN) INC

No trades
See on Supercharts

2269 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2269 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company